21-42535534-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001320537.2(SLC37A1):c.334G>A(p.Val112Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000164 in 1,614,102 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001320537.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC37A1 | NM_001320537.2 | c.334G>A | p.Val112Met | missense_variant | 5/20 | ENST00000352133.3 | NP_001307466.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC37A1 | ENST00000352133.3 | c.334G>A | p.Val112Met | missense_variant | 5/20 | 1 | NM_001320537.2 | ENSP00000344648.2 | ||
SLC37A1 | ENST00000398341.7 | c.334G>A | p.Val112Met | missense_variant | 6/21 | 1 | ENSP00000381383.3 |
Frequencies
GnomAD3 genomes AF: 0.000545 AC: 83AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000274 AC: 69AN: 251458Hom.: 1 AF XY: 0.000250 AC XY: 34AN XY: 135900
GnomAD4 exome AF: 0.000125 AC: 182AN: 1461800Hom.: 1 Cov.: 30 AF XY: 0.000129 AC XY: 94AN XY: 727198
GnomAD4 genome AF: 0.000545 AC: 83AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.000497 AC XY: 37AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 22, 2024 | The c.334G>A (p.V112M) alteration is located in exon 6 (coding exon 4) of the SLC37A1 gene. This alteration results from a G to A substitution at nucleotide position 334, causing the valine (V) at amino acid position 112 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at